Biscayne Pharmaceuticals

OverviewSuggest Edit

Biscayne Pharmaceuticals is a pharmaceutical company. It aims to develop GHRH antagonists that inhibit tumor growth by blocking the activity of tumoral GHRH. In addition, the company offers GHRH agonists as a treatment for cardiac damage resulting from heart attacks and other cardiovascular disorders
StateClosed
TypePrivate
Founded2014

Key People/Management at Biscayne Pharmaceuticals

Samuel J. Reich

Samuel J. Reich

Chairman and Chief Executive Officer
Joshua Michael Hare

Joshua Michael Hare

Co-Founder
Show more

Biscayne Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2014

Biscayne Pharmaceuticals total Funding

$2.6 m
Show all financial metrics

Biscayne Pharmaceuticals Online and Social Media Presence

Embed Graph

Biscayne Pharmaceuticals Frequently Asked Questions

  • When was Biscayne Pharmaceuticals founded?

    Biscayne Pharmaceuticals was founded in 2014.

  • Who are Biscayne Pharmaceuticals key executives?

    Biscayne Pharmaceuticals's key executives are Samuel J. Reich and Joshua Michael Hare.

  • Who are Biscayne Pharmaceuticals competitors?

    Competitors of Biscayne Pharmaceuticals include TG Therapeutics, GeoVax and Ablynx.